Excited to get this trial going with @celloradonc
Low-dose RT for polymetastaticdisease: Dr. @JJCaudell @MoffittNews outlines LIMETLESS, a single-arm phase I trial planned for 36 patients with >10 and up to 50 lesions, assessing technical feasibility of multisite online adaptive RT. #DAVAHeadAndNeckView quoted post on X